4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-067428
Corporate Controller & CAO sold 3,817 shares at an average $80.75 ($308,217)
- Corporate Controller & CAO acquired 2,850 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| German Christopher Paul Corporate Controller & CAO | 2025-07-09 | Option exercise 10b5-1 | +2,000 | $17.97 | $35,940 | 3,889 | D |
| German Christopher Paul Corporate Controller & CAO | 2025-07-09 | Option exercise 10b5-1 | +850 | $49.23 | $41,846 | 4,739 | D |
| German Christopher Paul Corporate Controller & CAO | 2025-07-09 | Sale 10b5-1 | −1,967 | $76.75 | $150,967 | 2,772 | D |
| German Christopher Paul Corporate Controller & CAO | 2025-07-09 | Sale 10b5-1 | −1,850 | $85.00 | $157,250 | 922 | D |
| Derivatives | |||||||
| German Christopher Paul Corporate Controller & CAO | 2025-07-09 | Option exercise · Stock Options (Right to Buy) 10b5-1 | −2,000 | 6,231 | D | ||
| German Christopher Paul Corporate Controller & CAO | 2025-07-09 | Option exercise · Stock Options (Right to Buy) 10b5-1 | −850 | 4,550 | D | ||
| Open-market sales · 3,817 sh · avg $80.75 · $308,217 | |||||||
Loading xslF345X05/tm2520691-2_4seq1.xml…